From: MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy
miRNA | Level†| Cancers‡ | References |
---|---|---|---|
miR-433-3p | Down | CRC tissues, LoVo, SW620, SW480, HCT116 cell lines | Zhang et al. (2018) |
 | Down | CRC: stage II vs stage I | Zhang et al. (2018) |
 | Down | CRC tissues, SW480, LoVo, HT29, Caco-2, SW620 lines | Li et al. (2018c) |
 | Down | CRC tissues and cell lines | Yan et al. (2018) |
 | Down | CRC tissues, SW620, HCT116, SW480, LoVo, HT29 lines | Li et al. (2017c) |
 | Down | GC: recurrent vs non-recurrent | Wang et al. (2021c) |
 | Down | GC tissues: stage IV vs stage II | Guo et al. (2013) |
 | Down | ESCC tissues and two cell lines | Li and Li (2021) |
 | Down | ESCC tissues | Cheng et al. (2020b) |
 | Down | OSCC tissues | Liu et al. (2020b) |
 | Down | OSCC tissues, TNM stage III/IV vs I/II | Wang et al. (2017) |
 | Down | OSCC tissues and five cell lines | Wang et al. (2015) |
 | Down | NSCLC tissues and A549, H1975 cell lines | Yu et al. (2022) |
 | Down | NSCLC tissues and A549, H522 cell lines | Guo et al. (2022) |
 | Down | NSCLC tissues and A549, H1299, H23, H1581 cell lines | Zhang et al. (2021) |
 | Down | NSCLC tissues | Liu et al. (2020c) |
 | Down | NSCLC tissues | Li et al. (2019a) |
 | Down | NSCLC tissues and four cell lines (A549, H460, H522) | Liu et al. (2018) |
 | Down | BLCA tissues and five cell lines (i.a. T24) | Wang et al. (2020b) |
 | Down | BLCA tissues and three cell lines (i.a. T24) | Xu et al. (2016b) |
 | Down | HCC tissues, stage III/IV vs I/II, four cell lines | Song et al. (2021) |
 | Down | HCC tissues | Ma et al. (2021a) |
 | Down | PDAC tissues and two cell lines (PANC-1, SW 1990) | Zhou et al. (2021b) |
 | Down | CeCa tissues and four cell lines | Liang et al. (2017) |
 | Down | OVCA tissue | Liang et al. (2016) |